Shukra Pharmaceuticals Ltd
₹40.13
(-5.00)%
Fri, 13 Feb 2026, 04:50 am
Health Technology
Pharmaceuticals: Major
24.5K1 Day
0 (0%)
No Result Found
Summary
Market Cap
1849.60
Net Profit
9.58
P/B
15.17
Sector P/E
32.61
P/E
99.32
EV/EBITDA
56.04
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
12.78
ROCE (Industry)
15.36
RONW (Industry)
13.46
ROE
15.90
ROCE
21.76
Debt/Equity
0.06
EPS (TTM)
0.67
Dividend Yield
0.02
Book Value
0.25
Interest Cover
23.61
Analysis
all
- Dividends paid are thoroughly covered by earnings (10.9x coverage).
- Shukra Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Shukra Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Shukra Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Shukra Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Shukra Pharmaceuticals has only been paying a dividend for 3 years, and since then there has been no growth.
- Whilst dividend payments have been stable, Shukra Pharmaceuticals has been paying a dividend for less than 10 years.
- Shukra Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Debt is not well covered by operating cash flow (4%, less than 20% of total debt).
- The level of debt compared to net worth has increased over the past 5 years (1.9% vs 41.1% today).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 50.96 | 50.96 | 50.96 | 50.96 | 50.96 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
| Public | 48.93 | 48.93 | 48.93 | 48.93 | 48.93 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 86.83 | 66.43 | 53.47 | 46.03 | 33.07 | 25.63 | 5.23 |
| Fibonacci | 66.43 | 58.64 | 53.82 | 46.03 | 38.24 | 33.42 | 25.63 |
| Camarilla | 46.12 | 44.25 | 42.38 | 46.03 | 38.64 | 36.77 | 34.90 |
Pivots Level: Classic
R3
+40.80
86.83
R2
+20.40
66.43
R1
+7.44
53.47
S1
-12.96
33.07
S2
-20.40
25.63
S3
-40.80
5.23
Moving Average
Period
Value
10-EMA
42.47
20-EMA
43.66
30-EMA
44.72
50-EMA
45.10
100-EMA
41.93
200-EMA
34.82
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 04 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 04 Oct 2025 | egm | ||
| 30 Aug 2025 | agm | ||
| 04 Jun 2025 | dividend | ₹0.01 Dividend /Share | 18 Sept 2025 |
| 29 Jan 2025 | split | 1:10 Splits of Equity Shares | 21 Mar 2025 |
| 15 Sept 2024 | agm | ||
| 30 Jul 2024 | egm | ||
| 29 May 2024 | dividend | ₹1.00 Dividend /Share | 24 Sept 2024 |
| 08 Apr 2024 | bonus | 3:1 Bonus Issue of Equity Shares | 20 Apr 2024 |
Peer Comparison
Shukra Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Divis Laboratories Ltd
About Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals is engaged primarily in the business of manufacture and marketing of pharmaceutical products.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1993
Headquarters
CEO
Dakshesh Shah
Employees
Contact
Website
http://www.shukrapharmaceuticals.com
info@shukrapharmaceuticals.com
Phone
91-079-66522247/27498515
Location
3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800